T cell receptor beta variable 16 (TRBV16)

T cell receptor beta variable 16 (TRBV16) refers to a **gene segment encoding a variable region of the beta chain of the T cell receptor (TCR)**, a key molecule in T cell-mediated antigen recognition within the adaptive immune response[2][4]. In humans, the **TRBV16 gene is annotated as a pseudogene**, meaning it is not believed to encode a functional protein product[2][1]. The broader TCR beta chain is produced by recombination of various variable (V), diversity (D), and joining (J) gene segments to create TCR diversity, and while many TRBV segments contribute functional diversity, TRBV16 is not among them in most people[2][4]. The TCR complex as a whole is essential for T cell activation and immune response, but TRBV16 is not considered a direct therapeutic target, nor are there approved drugs or therapies directed specifically at this segment[2][4][1]. Some studies have explored TRBV gene polymorphisms more broadly as biomarkers for immune diseases, but TRBV16 itself is not currently recognized as a distinct clinical biomarker[8]. **Key notes:** - TRBV16 is a pseudogene in the human genome (not expressed as a functional beta chain V region in the TCR)[2][1]. - It is not a therapeutic target but part of gene family contributing to TCR repertoire diversity in the general immune system context[2][1][4]. - The TCR beta chain, when functional, is involved in adaptive immune response, cellular signaling, and disease mechanisms in cancer, autoimmunity, and infection[4][6][8]. - No direct drugs interact with TRBV16, and its clinical significance is limited to the context of immune repertoire genetics[2][8][1].

Other names

TCRBV16S1TCRBV25S1A2PTBV25S1J1.2TCRBTCRBV25S1T-cell receptor TRB locus TRBV16*01T-cell receptor beta chain V regionTRBV16